Clinical efficacy of Jianqiao ancient moxibustion in treating chronic fatigue syndrome: a single-center randomized controlled superiority trial protocol - Report - MDSpire
Advertisement
Clinical efficacy of Jianqiao ancient moxibustion in treating chronic fatigue syndrome: a single-center randomized controlled superiority trial protocol
Clinical Report: Efficacy of Ancient Jianqiao Moxibustion for Chronic Fatigue Syndrome
Background
Chronic fatigue syndrome (CFS) is a debilitating condition affecting millions worldwide, characterized by persistent fatigue and various secondary symptoms. Moxibustion, a common TCM practice, is being investigated for its potential benefits in alleviating CFS symptoms.
90 patients with CFS and spleen–kidney yang deficiency
Intervention
Jianqiao ancient moxibustion vs. moxa box moxibustion
Treatment Frequency
3 times per week for 4 weeks
Primary Outcome Measure
Fatigue Scale-14
Follow-up Duration
16 weeks
Key Findings
The trial will assess the efficacy of Jianqiao ancient moxibustion compared to moxa box moxibustion.
Participants will be evaluated using multiple scales, including the Fatigue Scale-14 and the Spleen–Kidney Yang Deficiency Symptom Scale.
Infrared thermal imaging will be utilized to study changes in thermal characteristics post-treatment.
The study aims to provide insights into the mechanisms of moxibustion in CFS management.
Clinical Implications
The findings from this trial may contribute to the understanding of effective non-pharmacological treatments for CFS. If successful, Jianqiao ancient moxibustion could be integrated into therapeutic strategies for patients with spleen–kidney yang deficiency.
Conclusion
This trial aims to clarify the clinical efficacy of Jianqiao ancient moxibustion in treating CFS.
